Brandon Couillard
Stock Analyst at Wells Fargo
(4.14)
# 463
Out of 4,944 analysts
141
Total ratings
53.33%
Success rate
12.66%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Maintains: Equal-Weight | $19 → $14 | $12.46 | +12.36% | 3 | Aug 8, 2025 | |
| MLAB Mesa Laboratories | Upgrades: Equal-Weight | $100 → $67 | $63.27 | +5.90% | 3 | Aug 8, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $330 → $315 | $285.52 | +10.33% | 5 | Aug 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $60 → $50 | $32.36 | +54.51% | 5 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Overweight | $19 → $16 | $12.66 | +26.38% | 5 | Aug 4, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $245 → $265 | $274.76 | -3.55% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $245 → $265 | $271.71 | -2.47% | 12 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Overweight | $180 → $175 | $121.40 | +44.15% | 2 | Jul 30, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $78 → $95 | $116.41 | -18.39% | 4 | Jul 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $570 → $565 | $477.41 | +18.35% | 6 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $210 → $205 | $205.72 | -0.35% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $59 | $52.83 | +11.68% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $6 | $6.03 | -0.50% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,125 → $1,200 | $1,292.89 | -7.18% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $135 → $116 | $117.32 | -1.13% | 22 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $88.00 | +15.91% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $140.49 | +85.07% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $67.52 | +18.48% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $41.74 | +103.64% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.69 | +271.75% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $20.89 | +10.10% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.73 | +1,673.29% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.81 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.86 | +284.62% | 2 | Oct 13, 2017 |
CareDx
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $12.46
Upside: +12.36%
Mesa Laboratories
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $63.27
Upside: +5.90%
Waters
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $330 → $315
Current: $285.52
Upside: +10.33%
Bruker
Aug 5, 2025
Maintains: Overweight
Price Target: $60 → $50
Current: $32.36
Upside: +54.51%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $12.66
Upside: +26.38%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $274.76
Upside: -3.55%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $271.71
Upside: -2.47%
Repligen
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $121.40
Upside: +44.15%
GeneDx Holdings
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $78 → $95
Current: $116.41
Upside: -18.39%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Overweight
Price Target: $570 → $565
Current: $477.41
Upside: +18.35%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $210 → $205
Current: $205.72
Upside: -0.35%
May 30, 2025
Initiates: Overweight
Price Target: $59
Current: $52.83
Upside: +11.68%
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $6.03
Upside: -0.50%
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,292.89
Upside: -7.18%
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $117.32
Upside: -1.13%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $88.00
Upside: +15.91%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $140.49
Upside: +85.07%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $67.52
Upside: +18.48%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $41.74
Upside: +103.64%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.69
Upside: +271.75%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $20.89
Upside: +10.10%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.73
Upside: +1,673.29%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.81
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.86
Upside: +284.62%